Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration

CARLSBAD, Calif. , July 17, 2017 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has earned a $10 million milestone payment from Biogen associated with the validation of an undisclosed neurological disease target. Ionis and Biogen have a broad strategic